Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US Medicare's planned cardiac test coverage may depress ICD (implantable cardioverter defibrillator) demand

This article was originally published in Clinica

Executive Summary

US analysts are at odds over whether Medicare's proposed plan to pay for a new cardiac test will curtail demand for implantable cardioverter defibrillators (ICDs). The Microvolt T-wave Alternans test is intended to identify those patients who are currently eligible for defibrillators, but are highly unlikely to ever need a shock.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT050558

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel